A clinical trial to observe patients with a diagnosis of COVID-19, who have previously taken part in an AT-527 COVID-19 clinical trial

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

  • Infectious Diseases
  • COVID-19 Pneumonia
  • COVID-19
Please note that the recruitment status of the trial at your site may differ from the overall study status because some study sites may recruit earlier than others.
Trial Status:

Terminated

This trial runs in
Cities
  • Aalborg
  • Ankara
  • București
  • Caracal
  • Ciudad de México
  • Creixomil
  • Distrito Federal
  • el-salitre
  • gesves
  • Guadalajara
  • İstanbul
  • Ivano-Frankivs'k
  • İzmir
  • Kropyvnytskyi
  • Kyiv
  • Köln
  • København
  • Mar del Plata
  • Matosinhos
  • Paraná
  • Pernambuco
  • Roskilde
  • Sibiu
  • São Paulo
  • thuin
  • Torreón
  • Trabzon
  • Vinnytsia
  • Zaporizhzhia
  • Zürich
Trial Identifier:

NCT05059080 2021-000627-12 CV43140

      Show trial locations

      The source of the below information is public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc.. It has been summarised and edited into simpler language. For more information about this clinical trial see the For Expert tab on the specific ForPatients page or follow these links to https://clinicaltrials.gov and/or https://euclinicaltrials.eu and/or https://www.isrctn.com.

      The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc., and has not been edited.

      Results Disclaimer

      Trial Summary

      This study will evaluate the long-term sequelae of COVID-19 in patients diagnosed with COVID-19 who previously enrolled in a RO7496998 (AT-527) study (i.e. parent study NCT04889040 [CV43043]), for approximately 6 months after the end of the parent study.

      Hoffmann-La Roche Sponsor
      NCT05059080,CV43140,2021-000627-12 Trial Identifier
      COVID-19, Long COVID Condition
      Official Title

      A Multicenter, Observational, 6-Month Follow-up Study of Patients With COVID-19 Previously Enrolled in a RO7496998 (AT-527) Study

      Eligibility Criteria

      All Gender
      ≥12 Years Age
      No Healthy Volunteers
      Inclusion Criteria
      • Participant was diagnosed with COVID-19 and enrolled in a Phase III RO7496998 (AT-527) COVID-19 study
      Exclusion Criteria
      • Participation in an interventional study at the time of enrollment or plans to enroll in an interventional study during this study.
      • Any serious medical condition or abnormality of clinical laboratory tests that, in the investigator's judgment, precludes the patient's safe participation in and completion of the study

      For the latest version of this information please go to www.forpatients.roche.com

       

      Related Trials

      Use our search to find other trials on ForPatients in related disease areas.

      COVID-19 Pneumonia COVID-19

      Clinical Research Explained

      Information about what clinical trials and observational studies are. Understand why you might want to take part in clinical research and why diversity in clinical research is important.

      Find out now